Evolution of severe obesity and associated comorbidities in persons living with HIV with and without bariatric surgery at short and long term follow up
Main Article Content
Abstract
Objectives: Obesity and related comorbidities are increasing among people living with HIV (PLWH). This study compared the evolution of severe obesity and related comorbidities in PLWH with (cases) or without (controls) bariatric surgery (BS).
Methods: Monocentric retrospective comparison of PLWH with severe obesity (body mass index (BMI) ≥40 kg/m2 or BMI ≥ 35 together with ≥ 1 comorbidity (diabetes, dyslipidemia, arterial hypertension, sleep apnea, cardiovascular events)) between cases at baseline, 1, 2, 5 and 10 years after BS or as controls matched (1:3) on age, gender, ethnicity and severe obesity criteria.
Results: Between 2006 and 2019, we included 27 cases and 73 controls: 84% female, median age 43 years, 78% originated from sub-Saharan Africa; median time with HIVRNA <50 cp/ml 6 years in both groups. BMI decreased from 41 (baseline) to 29 kg/m2 at 2 years after BS (p=0.002) while controls remained at 37 kg/m2 both at baseline and 2 years. At 5 and 10 years, BMI was ≤31 in cases while controls remained ≥ 35 kg/m2. Comorbidities favorable evolution at 2 years occurred in 50% of cases versus 12.5% in controls for diabetes, 44% versus 0 (p=0.006) for hypertension and 90% versus 0 (p<0.0001) for sleep apnea. Post-operative complications rate was 11% and HIV infection remained under control after BS.
Conclusion: Bariatric surgery is a safe and efficient treatment of severe obesity and its related comorbidities among patients with well-controlled HIV at short, middle and long terms with no impact on control of HIV disease.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Farahani M, Mulinder H ,Farahani A, Marlink R. Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis. Int J STD AIDS. 2017 Jun;28(7):636-650.
3. Gutierrez J, Albuquerque ALA, Falzon L. HIV infection as vascular risk: A systematic review of the literature and meta-analysis. PLoS One. 2017 May 11;12(5):e0176686.
4. Bailin SS, Gabriel CL, Wanjalla CN, Koethe JR. Obesity and Weight Gain in Persons with HIV. Curr HIV/AIDS Rep. 2020 Apr;17(2):138-150.
5. World Health Organization. Obesity and overweight. Published March1st, 2024. Accessed June 21st, 2024. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
6. Van den Heede Koen, Ten Geuzendam Belinda, Dossche Dorien, Janssens Sabine, Louwagie Peter, Vanderplanken Kirsten, Jonckheer Pascale. Bariatric surgery in Belgium: organisation and payment of care before and after surgery. Health Services Research (HSR). Brussels. Belgian Health Care Knowledge Centre (KCE). 2020. KCE Reports 329. DOI: 10.57598/R329C.
7. Hasse B, Iff M, Ledergerber B, et al. Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study. Open Forum Infect Dis. 2014 Jul 1;1(2):ofu040.
8. Shah S, Hindley and Hill A. Are new antiretroviral treatments increasing the risk of weight gain? Drugs. 2021;81:299-315.
9. Golzarand M, Toolabi K, Farid R. The bariatric surgery and weight losing: a meta-analysis in the long- and very long-term effects of laparoscopic adjustable gastric banding, laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy on weight loss in adults. Surg Endosc. 2017 Nov;31(11):4331-4345.
10. Gao M, Piernas C, Astbury NM, Hippisley-Cox J, O'Rahilly S, Aveyard P, Jebb SA. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 2021 Jun;9(6):350-359. doi: 10.1016/S2213-8587(21)00089-9. Epub 2021 Apr 28. PMID: 33932335; PMCID: PMC8081400.
11. Sean Wharton , David C W Lau, Michael Vallis, and al. Obesity in adults: a clinical practice guideline. CMAJ 2020 Aug 4;192(31):E875-E891.
12. Ania Jastreboff, Louis Aronne, Nadia Ahmad and al for the SURMOUNT-1 Investigators. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med 2022; 387:205-216.
13. Nicholas L Syn, David E Cummings, Louis Z Wang, and al. Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants. Lancet 2021 May 15;397(10287):1830-1841.
14. McCarty TR, Sharma P, Lange A, Ngu JN, David A, Njei B. Safety of Bariatric Surgery in Morbidly Obese Patients with Human Immunodeficiency Virus: A Nationwide Inpatient Sample Analysis, 2004-2014. Bariatr Surg Pract Patient Care. 2020 Sep 1;15(3):116-123.
15. Akbari K, Som R, Sampson M, Abbas SH, Ramus J, Jones G. The Effect of Bariatric Surgery on Patients with HIV Infection: a Literature Review. Obes Surg. 2018 Aug;28(8):2550-2559.
16. EACS version 12. Published October 2023. Accessed June 21st, 2024. https://www.eacsociety.org/media/guidelines-12.0.pdf
17. Sharma G, Strong AT, Boules M, Tu C et al. Comparative Outcomes of Bariatric Surgery in Patients With and Without Human Immunodeficiency Virus. Obes Surg. 2018 Apr;28(4):1070-1079.
18. El Kamari V, Hileman CO, Kosco J, Mccomsey GA. Sleeve Gastrectomy Compared With Roux-En-Y Gastric Bypass in Individuals Living With HIV. J Acquir Immune Defic Syndr. 2020 Aug 1;84(4):28-31.
19. O’Brien PE, Hindle A, Brennan L, Skinner S, Burton P, Smith A et al. Long-Term Outcomes After Bariatric Surgery: a Systematic Review and Meta-analysis of Weight Loss at 10 or More Years for All Bariatric Procedures and a Single-Centre Review of 20-Year Outcomes After Adjustable Gastric Banding. Obes Surg. 2019 Jan;29(1):3-14.
20. Salminen P, Helmiö M, Ovaska J, Juuti A, Leivonen M, Peromaa-Haavisto P et al. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-En-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial. JAMA. 2018 Jan 16;319(3):241-254.
21. Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014 Mar;149(3):275-87.
22. Grönroos S, Helmiö M, Juuti A, Tiusanen R, Hurmes S, Löyttyniemi E et al. Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss and Quality of Life at 7 Years in Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial. JAMA Surg. 2021 Feb 1;156(2):137-146.
23. Alfa-Wali M, Seechurn S, Ayodeji O et al. Outcomes of bariatric surgery in human immunodeficiency virus positive individuals: a single center experience. Minerva Chir. 2016 Aug;71(4):233–8.
24. Zivich S, Cauterucci M, Allen S, Vetter M, Vinnard C. Long-term virologic outcomes following bariatric surgery in patients with HIV. Obes Res Clin Pract. 2015 Nov-Dec;9(6):633–5.
25. Puzziferri N, Roshek TB 3rd, Mayo HG, Gallagher R, Belle SH, Livingston EH. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014 Sep 3;312(9):934-42.
26. Wilhelm SM, Young J, Kale-Pradhan PB. Effect of bariatric surgery on hypertension: a meta-analysis. Ann Pharmacother. 2014 Jun;48(6):674-82
27. Schauer PR, Bhatt DL, Kirwan JP et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med. 2017 Feb 16;376(7):641-651.
28. Leena Zino, Jurjen S. Kingma, Catia Marzolini, Olivier Richel, David M. Burger, and Angela Colbers. Implications of Bariatric Surgery on the Pharmacokinetics of Antiretrovirals in People Living with HIV Clin Pharmacokinet. 2022; 61(5): 619–635.
29. Mitchell LJ, Ball LE, Ross LJ, Barnes KA, Williams LT. Effectiveness of Dietetic Consultations in Primary Health Care: A Systematic Review of Randomized Controlled Trials. J Acad Nutr Diet. 2017 Dec;117(12):1941-1962
30. Sax PE, Erlandson KM, Lake JE et al. Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials. Clin Infect Dis. 2020 Sep 12;71(6):1379-1389.
31. Krzysztof Walczak , Lucyna Sieminska. Obesity and Thyroid Axis Int J Environ Res Public Health. 2021 Sep 7;18(18):9434.